Syndax Pharmaceuticals, Inc. (SNDX) has a market capitalization of $2.15B and trades at $24.43. The 52-week range is 8.58-25.59.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -7.4, Earnings Per Share (EPS) of $-3.30, annual revenue of $172.35M.
The stock has a beta of 0.41, operates in the Healthcare sector.
